The global egg freezing and embryo banking market size is calculated at USD 5.41 billion in 2024, grew to USD 6.32 billion in 2025 and is anticipated to reach around USD 25.63 billion by 2034. The market is expanding at a healthy CAGR of 16.83% between 2024 and 2034. The Europe egg freezing and embryo banking market size is evaluated at USD 1.95 billion in 2024 and is expected to grow at a fastest CAGR of 16.95% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Egg Freezing and Embryo Banking Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Egg Freezing and Embryo Banking Market, by Type, 2024-2034
8.1.1 Donor
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Non-donor
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Egg Freezing and Embryo Banking Market, by Preservation, 2024-2034
9.1.1. Egg Freezing
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Embryo Freezing
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Egg Freezing and Embryo Banking Market, by Age of Patient, 2024-2034
10.1.1. Under 35
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. 35-37
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. 38-40
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Over 42
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.1.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.2.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.3.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.4.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.5.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Preservation (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Age of Patient (2021-2034)
12.1. ReproTech LLC
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cryos International
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. CCRM Fertility
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. RMA Network
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Carrot Fertility
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. WINFertility
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Columbia University
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Shady Grove Fertility
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Kindbody
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample